Startup Space Opens up at Janssen Labs

In an email to BayBio, Janssen Labs announced its expansion into the Bay Area through a collaboration with the California Institute for Quantitative Biosciences (QB3) and Johnson & Johnson Innovation.

Since opening in January 2012, Janssen Labs in San Diego has hosted 32 independent healthcare companies from around the globe.

Opening this October, Janssen Labs@QB3 is 5,000 sq ft satellite site consisting of lab and office space within QB3’s newly renovated 24,000 sq ft location at 953 Indiana St., San Francisco, CA Similar to the flagship Janssen Labs in San Diego, Janssen Labs @QB3 will provide an open-innovation, no-strings-attached environment with shared equipment and modern facilities. Janssen Labs @QB3 companies will have access to QB3’s resources, which include legal and business advisors, assistance in grant writing for federal Small Business Innovation Research funds, and access to high-end equipment and technology at the University of California, San Francisco facilities. To apply or for more information about selection criteria contact Kara Bortone visit

Janssen Labs is part of Johnson & Johnson’s external research and development engine and provides a capital-efficient, resource-rich environment where independent emerging companies can progress their research.  The 30,000 square foot flagship facility opened in early 2012 in San Diego at Janssen’s West Coast Research Center and currently hosts 30 emerging life science companies.   Through recent expansion to additional life science hubs around the globe, Janssen Labs has established satellite locations that provide emerging companies with many of the advantages of being in a big company, without the capital investment. Janssen Labs offers a variety of offerings between the flagship and satellite facilities including singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at Janssen Labs sites also have access to core research labs hosting specialized capital equipment and shared administrative areas. Additionally, Janssen Labs produces a year-round curriculum designed to assist innovators along the commercialization continuum.  Janssen Labs is an open innovation model, and the agreement for space does not grant Janssen any stake in the companies, nor will the companies have a guaranteed future affiliation with Janssen; but the models is designed to initiate a dialogue early and foster long term relationships with innovators in healthcare. Janssen Labs services and amenities vary depending on location.  For more information, visit